HSBC TUR.WAR.OP.END. FRE/ DE000HG5LZJ8 /
20/12/2024 21:37:16 | Var.-0.400 | Denaro21:59:22 | Lettera21:59:22 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
16.400EUR | -2.38% | 16.280 Quantità in denaro: 10,000 |
16.520 Quantità in lettera: 10,000 |
FRESENIUS SE+CO.KGAA... | 16.9559 - | 31/12/2078 | Call |
GlobeNewswire
24/04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil